Jounce Therapeutics, Inc. (JNCE)
Jounce Therapeutics, Inc. (JNCE) Company Bio
Jounce Therapeutics, Inc. focuses on developing cancer immunotherapy treatments that enable the immune system to attack tumors. The company in 2012 and is based in Cambridge, Massachusetts.
JNCE Stock Chart More Charts
JNCE Price/Volume Stats
| Current price | $6.01 |
| Prev. close | $6.51 |
| Day low | $5.94 |
| Day high | $6.58 |
| 50-day MA | $4.78 |
| 200-day MA | $5.84 |
| 52-week high | $25.53 |
| 52-week low | $2.66 |
| Volume | 272,500 |
| Avg. volume | 256,970 |
| Dividend yield | N/A |
| Market Cap | 198.16M |
JNCE Returns
| 1-mo | 40.09% |
| 3-mo | 109.41% |
| 6-mo | -9.76% |
| 1-year | -74.99% |
| 3-year | N/A |
| 5-year | N/A |
| YTD | 78.34% |
| 2018 | -73.57% |
| 2017 | N/A |
| 2016 | N/A |
| 2015 | N/A |
| 2014 | N/A |
Loading social stream, please wait...